TARGETING THE SCS CLEARSIDE BIOMEDICAL
Live / Allowed — Fifth extension granted (statement of use) (as of 05 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97667367
- Mark type
- Design + words
- Filed
- 08 Nov 2022
- Published for opposition
- 15 Aug 2023
- Attorney of record
- Bassam N. Ibrahim
Goods and services
- Class 005 — Pharmaceuticals: Ocular pharmaceuticals; Ophthalmic preparations
- Class 010 — Medical apparatus: Medical devices, namely, a needle-based injection system for delivery of pharmaceutical preparations comprised of injection instruments with needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceutical preparations to eye tissue comprised of injection instruments with needles; Injection needles for suprachoroidal injections; Injection needles
Owner
- Clearside Biomedical, Inc., Alpharetta, GA, US
- Clearside Biomedical, Inc., Alpharetta, GA, US
Prosecution history
- 05 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2026 — SOU EXTENSION 5 GRANTED
- 01 Apr 2026 — SOU EXTENSION 5 FILED
- 03 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2025 — SOU EXTENSION 4 GRANTED
- 08 Oct 2025 — SOU EXTENSION 4 FILED
- 08 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 3 GRANTED
- 10 Apr 2025 — SOU EXTENSION 3 FILED
- 10 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2024 — SOU EXTENSION 2 GRANTED